journal article·2023-10

Detection of SARS‐CoV‐2 Virus Concentration Using a Simple Structure of Binary Photonic Crystal Sensor

Sofyan A. Taya, Malek G. Daher, Abdulkarem H. M. Almawgani, Ayman Taher Hindi, Ilhami Colak

physica status solidi (a)· Volume 220· Issue 19
Publisher page

Abstract

The scientific community works hard on developing reliable, rapid, highly sensitive, and low‐cost techniques to detect severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2). The current techniques can occasionally produce false‐positive results. The development of novel approaches for the identification of SARS‐CoV‐2 is a significant area of research because of the limitations of current methods. A biosensor based on a defective binary photonic crystal (PCL) is proposed to detect SARS‐CoV‐2 concentration herein. The model of pathogen concentration‐dependent refractive index of the analyte is taken into consideration. The concept of operation of the PCL sensor is based on the defect mode shift when any change in the refractive index of the defect layer occurs. The transmission spectra of the PCL are plotted and studied. An optimum incident angle of 80° and a defect layer thickness of 5 μm are found. The relationship between the defect mode's wavelength and the concentration of SARS‐CoV‐2 is investigated and a sensitivity of 2648.3 nm RIU−1 is attained.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Retinal and Optic Conditions · Advanced Biosensing Techniques and Applications · Biosensors and Analytical Detection

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Physics Department Islamic University of Gaza P.O. Box 108 Gaza Palestine

Electrical Engineering Department College of Engineering Najran University Najran Kingdom of Saudi Arabia

Department of Electrical and Electronics Engineering Nisantasi University Istanbul Turkey

Funding

Najran University

References (29)

Show source-provided references
1. 10.3390/v1206059810.3390/v12060598 ↗
2. 10.1002/tbio.20220000110.1002/tbio.202200001 ↗
3. 10.1002/advs.20210449510.1002/advs.202104495 ↗
4. 10.1186/s13643-021-01689-310.1186/s13643-021-01689-3 ↗
5. 10.3390/vaccines803044310.3390/vaccines8030443 ↗
6. 10.3390/bios902006510.3390/bios9020065 ↗
7. 10.1007/s11082-021-02981-110.1007/s11082-021-02981-1 ↗
8. 10.1364/AO.41701510.1364/AO.417015 ↗
9. 10.1016/j.cjph.2022.03.03210.1016/j.cjph.2022.03.032 ↗
10. 10.1166/jnn.2007.44410.1166/jnn.2007.444 ↗
11. 10.1002/jbio.20220000110.1002/jbio.202200001 ↗
12. 10.1063/5.002221110.1063/5.0022211 ↗
13. Taya S. A. · J. Phys. · 2022 · 96 · . 215
14. 10.3390/s13020201110.3390/s130202011 ↗
15. 10.1515/zna-2022-021210.1515/zna-2022-0212 ↗
16. 10.2307/j.ctvcm4gz910.2307/j.ctvcm4gz9 ↗
17. 10.2528/PIER0811210510.2528/PIER08112105 ↗
18. 10.1016/j.ijleo.2010.03.00110.1016/j.ijleo.2010.03.001 ↗
19. 10.3390/mi1403066810.3390/mi14030668 ↗
20. 10.1039/D2AN00438K10.1039/D2AN00438K ↗
21. 10.1088/1402-4896/ac5ff710.1088/1402-4896/ac5ff7 ↗
22. Schreiber B. · Pharm. Eng. · 2013 · 33 · 1
23. 10.1007/s10043-019-00564-w10.1007/s10043-019-00564-w ↗
24. 10.1021/cm020100z10.1021/cm020100z ↗
25. 10.1016/j.sna.2019.11176710.1016/j.sna.2019.111767 ↗
26. 10.1088/1402-4896/abd49c10.1088/1402-4896/abd49c ↗
27. 10.1016/j.ijleo.2020.16509710.1016/j.ijleo.2020.165097 ↗
28. 10.1016/j.physb.2021.41285410.1016/j.physb.2021.412854 ↗
29. 10.1016/j.yofte.2019.10212310.1016/j.yofte.2019.102123 ↗